Drug Development in Endometriosis and Adenomyosis: It Takes More Than Just Good Science-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Drug Development in Endometriosis and Adenomyosis: It Takes More Than Just Good Science

Published:2018-07 Issue:9 Volume:25 Page:1318-1329
ISSN:1933-7191
Container-title:Reproductive Sciences
language:en
Short-container-title:Reprod Sci

Author:

Groothuis Patrick G.¹^ORCID,Guo Sun-Wei²³

Affiliation:

1. Preclinical Department, Synthon Biopharmaceuticals bv, Nijmegen, the Netherlands

2. Shanghai OB/GYN Hospital, Fudan University, Shanghai, China

3. Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Fudan University, Shanghai, China

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynaecology

Link

http://journals.sagepub.com/doi/pdf/10.1177/1933719118785767

Reference65 articles.

1. Endometriosis

2. EPIDEMIOLOGY OF ENDOMETRIOSIS

3. Endometriosis-associated dyspareunia: the impact on women's lives

4. Quantification of the impact of endometriosis symptoms on health-related quality of life and work productivity

5. Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Attitudes and perceptions of affected women towards endocrine endometriosis therapy: an international survey based on free-word association networks;Human Reproduction;2023-10-25

2. Trends, challenges, and success factors in pharmaceutical portfolio management: Cognitive biases in decision-making and their mitigating measures;Drug Discovery Today;2023-10

3. Bioluminescent imaging in induced mouse models of endometriosis reveals differences in four model variations;Disease Models & Mechanisms;2021-08-01

4. Popularity of endocrine endometriosis drugs and limited alternatives in the present and foreseeable future: A survey among 1420 affected women;European Journal of Obstetrics & Gynecology and Reproductive Biology;2021-07

5. Efficacy and safety of sanjiezhentong capsules, a traditional chinese patent medicine, on long-term management of endometriosis: A randomized controlled trial;Reproductive and Developmental Medicine;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3